0001209191-12-028568.txt : 20120516 0001209191-12-028568.hdr.sgml : 20120516 20120516161058 ACCESSION NUMBER: 0001209191-12-028568 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120514 FILED AS OF DATE: 20120516 DATE AS OF CHANGE: 20120516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mazur Marc CENTRAL INDEX KEY: 0001361226 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31564 FILM NUMBER: 12848924 MAIL ADDRESS: STREET 1: 31 WEST 52ND ST. 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fibrocell Science, Inc. CENTRAL INDEX KEY: 0000357097 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870458888 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 405 EAGLEVIEW BOULEVARD CITY: EXTON STATE: PA ZIP: 19341 BUSINESS PHONE: 484-713-6000 MAIL ADDRESS: STREET 1: 405 EAGLEVIEW BOULEVARD CITY: EXTON STATE: PA ZIP: 19341 FORMER COMPANY: FORMER CONFORMED NAME: ISOLAGEN INC DATE OF NAME CHANGE: 20020320 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN FINANCIAL HOLDING INC /DE DATE OF NAME CHANGE: 19960330 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN FINANCIAL HOLDING INC /CO DATE OF NAME CHANGE: 19921008 4 1 c28777_4x0.xml MAIN DOCUMENT DESCRIPTION X0305 4 2012-05-14 0000357097 Fibrocell Science, Inc. FCSC 0001361226 Mazur Marc C/O 405 EAGLEVIEW BOULEVARD EXTON PA 19341 1 0 0 0 Series E Preferred Stock .25 2012-05-14 4 A 0 100000 A Common Stock 100000 500000 D Warrant to Purchase Common Stock .30 2012-05-14 4 A 0 100000 A Common Stock 100000 600000 D The Series E Preferred Stock is immediately exercisable and does not have an expiration date. Each share of Series E Preferred Stock and each Warrant were purchased together as a Unit, for a combined purchase price of $1,000 per Unit. Mr. Mazur purchased 25 Units, for a total purchase price of $25,000. The Warrants may be exercised beginning on the date on which the Company receives approval from its shareholders to file, and subsequently files, an amendment to its Certificate of Incorporation increasing the number of its authorized shares of Common Stock to an amount greater than 250,000,000 shares. The Warrants expire 5 years after the initial exercise date described in Footnote 3. Marc Mazur 2012-05-16